J Cancer 2020; 11(8):2360-2370. doi:10.7150/jca.39511 This issue Cite
Research Paper
1. School of Traditional Chinese Medicine, Southern Medical University, Guangdong Guangzhou, 510515, China
2. NanFang Hospital, Guangdong Guangzhou, 510515, China
*These authors contributed equally to this work
Circular RNAs (circRNAs) are involved in cancer development via inhibition of miRNAs, which are associated with differentiation, proliferation, migration, and carcinogenicity. Curcumin has antioxidant and anti-cancer properties, and it has also been used as a radiosensitizer. In this study, we explored the potential relationships among curcumin, circRNAs, and nasopharyngeal carcinoma (NPC). We compared the differences in circRNA levels in NPC cell lines after radiotherapy and after treatment with curcumin, using a high-throughput microarray. Further, a circRNA-miRNA-mRNA interaction network between radiation resistance NPC cell lines and tumor stem cells was constructed by applying bioinformatics. Finally, it was demonstrated by reverse transcription-quantitative polymerase chain reaction assay and wound healing assay that curcumin could enhance radiosensitization of NPC cell lines via mediating regulation of tumor stem-like cells by the "hsa_circRNA_102115"-"hsa-miR-335-3p"-"MAPK1" interaction network.
Keywords: nasopharyngeal carcinoma, circRNA, tumor stem-like cells, radiosensitization, curcumin
Nasopharyngeal carcinoma (NPC) is an endemic tumor in certain parts of Southeast Asia, especially China (Canton) and Hong Kong [1]. Epstein-Barr virus (EBV) infection, genetic, environmental, and dietary factors contribute to the development of NPC [2]. Few genetic signatures have been previously identified for the early diagnosis and long-term risk prognosis of NPC [3, 4]. For the past decades, chemotherapy combined with radiotherapy is the first therapeutic option in loco-regionally advanced NPC [5]. With treatment, the rates of locoregional relapse, distant metastases, and five-year survival are 16%, 31.5%, and 71.4%, respectively, which can be considered as satisfactory [3]. Accumulating evidence has substantiated that cancer stem cells (CSCs) or tumor side populations (SP) have self-renewal and stem-like cell properties, and play a crucial role in tumor resistance and relapse to radiotherapy [6]. Cancer stem cells are related to tumor metastasis and relapse after standard treatment in NPC [7].
Curcumin (CUR), a natural bioactive compound extracted from a traditional Chinese medicinal herb turmeric (Curcuma longa), has been reported to exhibit potent antitumor activities against different types of cancer, including NPC in both in vivo and in vitro models [8]. Our previous studies have shown that curcumin could enhance radiosensitization in NPC by variant pathways through the regulation of different coding- or noncoding-RNAs [9]. Current studies have shown that curcumin exerts prominent inhibitory effects on various cancer stem cells through different pathways. Curcumin attenuates the malignant potential of glioblastoma stem cells by induction of reactive oxygen species (ROS) and activation of the mitogen-activated protein kinase (MAPK) pathway [10]. Curcumin suppresses metastasis in colorectal cancer (CRC) by modulating crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment, at least in part by the mediation of transforming growth factor-β (TGF-β) and epithelial-mesenchymal transition (EMT) [11]. Curcumin also enhances the effects of cisplatin by targeting the CSCs CD166+/EpCAM+ subpopulation in non-small cell lung cancer cell lines (NSCLC) by p21- and cyclin D1-mediated tumor cell inhibition [12]. Further, curcumin inhibits EMT and migration of breast CSCs by promoting the E-cadherin/β-catenin negative feedback loop [13]. Curcumin is a potential drug to augment the radiosensitivity of NPC by inhibiting the proliferation and differentiation of NPC stem-like cells.
Noncoding RNAs (ncRNA) play critical roles in the regulation of cellular mechanisms and are classified as microRNAs (miRNA), long non-coding RNAs (lncRNA), and circular RNAs (circRNA), making up 95% of the total RNA in the eukaryotic transcription [14]. The competing endogenous RNA (ceRNA) mechanism suggests that lncRNAs and circRNAs serve as natural miRNA sponges by competitively binding to miRNA response elements (MREs) and suppressing their expression and function [15]. Accumulating evidence suggests that circRNAs also exert the same effects. CircRNA_100290 was found to inhibit the proliferation of oral cancer in vitro and in vivo by regulation of CDK6 expression and sponging up miR-29b family members [16]. CircRNA-000911 was found to suppress proliferation, migration, and invasion of breast cancer cells and promoted apoptosis via miR‑449a, Notch1, and the nuclear factor-κB (NF-κB) pathway [17]. The inhibition of proliferation and invasion of cervical cancer by the miR-506/Snail-2 pathway has also been reported after the silencing of circRNA-000284 [18]. Meanwhile, very few studies have demonstrated that circRNAs play a significant role in regulating the proliferation and differentiation of CSCs or SP. It was reported that circVRK1 could suppress the expansion and self-renewal capacity of breast CSCs via the circRNA/ miRNA network [19]. But just a very few published papers have shown the correlation between circRNAs and NPC, especially radiosensitization or CSCs related. As described by Ke Z, they demonstrated circHIPK3 facilitated NPC progression through protecting ELF3 from miR-4288-mediated silencing, which suggested that the circHIPK3-miR-4288-ELF3 regulatory loop might be a potential target for NPC prevention [20].
Most of the NPC patients are initially diagnosed with undifferentiated and non-keratinizing carcinoma [21]. Studies have shown that circRNAs are abundantly expressed in epidermal stem cells (EpSCs), and the expression markedly changes in an integrated manner during the differentiation of the cancer cells [22]. Atkinson et al. (2017) suggested that circRNAs take part in the cellular irradiation response by demonstrating KIRKOS-71 and KIRKOS-73 as potential diagnostic biomarkers of radiotherapy [23]. Interestingly, with further exposure to radiation, there was marked attenuation of adherence leading to enhanced radio-resistance and formation of a stable radioresistant NPC cell line. Based on the findings of these studies, we hypothesized that continuous stimulation or injury of nasopharyngeal epithelial lesions induce abnormal expression of circRNAs leading to the differentiation of nasopharyngeal epithelial stem cells along with an attempt of self-renewal to replace the impaired cells. Unfortunately, a vast majority of mutations lead to carcinogenesis and the formation of highly radioresistant NPC stem-like cells. Therefore, it is essential to explore the potential relationship among curcumin, circRNAs, and NPC or NPC stem-like cells.
The human NPC cell line CNE-2 was obtained from Sun Yat-sen University (Guangzhou, China). The cells were cultured in RPMI-1640 medium (Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (Thermo Fisher Scientific, Inc.) at 37 °C in a humid incubator in the presence of 5% CO2. Curcumin was dissolved in DMSO (Sigma-Aldrich, USA) and filtered through a 0.22-μm filter (Millipore, Merck KGaA, Darmstadt, Germany). The curcumin solution was diluted in fresh broth to a concentration of 20 μmol/L before use [24]. The cells were divided into three groups: CNE-2 group (NC), IR (irradiation) group (IM), and IR + 20 μmol/L CUR group (IC).
Total RNA was extracted using TRIzol reagent (Invitrogen) and quantified using NanoDrop ND-1000 (Thermo Fisher Scientific, Inc.). The sample preparation and microarray hybridization were performed according to a standard protocol (Arraystar, MD, USA). Briefly, total RNAs were digested with RNase R (Epicentre, Inc., Wisconsin, USA ) to remove the linear RNAs and enrich the circular RNAs. The enriched circular RNAs were amplified and transcribed into fluorescent cRNA utilizing a random priming method (Arraystar Super RNA Labeling Kit, Arraystar). The labeled cRNAs were hybridized onto human circRNA array V2 (8x15K, Arraystar). After washing the slides, the arrays were scanned by Agilent Scanner G2505C (Agilent Technologies, USA).
Agilent Feature Extraction software (version 11.0.1.1, Agilent Technologies) was used to analyze the acquired array images. Quantile normalization and subsequent data processing were performed using R software (limma package). Differentially expressed circRNAs with a significant difference between the two groups were identified by volcano plots. The differentially expressed circRNAs in the two samples were identified through filtering based on fold change. Hierarchical clustering was performed to detect the discernible circRNAs expression pattern in the samples.
Hierarchical clustering is the primary statistical method for finding the relatively homogeneous clusters of cases based on measured characteristics in large datasets [25]. Cluster and TreeView programs were used to reveal the hidden structures of the circRNA expression in the two groups.
The circRNA/miRNA network was predicted by miRNA target prediction software (Arraystar) based on MiRanda and TargetScan and was constructed by Cytoscape 3.01 [26]. The target mRNAs of the miRNAs were surveyed by DIANA-miRPath (p < 0.05, MicroT < 0.8) and the intergenic interaction network constructed based on the KEGG pathway database [27]. The molecular function, biological process, cellular component, protein domain, site of expression, and Catalogue of Somatic Mutations in Cancer (COSMIC) of target miRNAs were analyzed by FunRich (v 3.1.3) (p < 0.05) [28].
A single-cell suspension of CNE-2 was seeded in 6-well plates and cultured until full confluence (cells for IC were exposed to 20 μmol/L CUR for 48 h in the beginning). A straight wound was induced by scratching with a sterile pipette tip which was washed twice with phosphate-buffered saline (PBS). The gap was observed and photographed under a microscope at 200X magnification.
Total RNA was extracted using TRIzol reagent (Thermo Fisher Scientific, Inc.) according to the manufacturer's instructions. The expression of mRNA and miRNA were determined by using SYBR Green Master Mix (Thermo Fisher Scientific, Inc.) and StepOne Plus quantitative PCR system (Thermo Fisher Scientific, Inc.) following the manufacturer's instructions. U6 and GAPDH were used as an internal control for miRNA and mRNA, respectively. The fold changes were calculated according to the 2-△△Ct equation. The list of all the primers enumerated in Supplementary Table S1.
CNE-2 cells were selected after irradiation used for the IM group. Different cells were counted and seeded at different cell densities in triplicates in six-well cell culture plates. Nonirradiated and irradiated cells were grown for 7 to 14 days, allowing the surviving cells to produce macroscopic colonies, each consisting of 50 or more cells and stained with Giemsa solution (1:999 with distilled water). The surviving fractions (SF) were calculated by dividing the PE by the PE of the non-irradiated control. Sensitization enhancement ratio was calculated by the division of SF2.
Cells were harvested and homogenized in the lysis buffer on ice using the proteo JET mammalian cell lysis reagent (Fermentas Life sciences, Israel). Protein concentration was determined using the Bio-Rad kit (Bio-Rad, Hercules, CA). The membranes with selected proteins were incubated at 4°C overnight with primary antibody against IGF1R (Cat #PA5-85986, Thermo Fisher Scientific, Inc.), MAPK1 (Cat #13-8600, Thermo Fisher Scientific, Inc.), MAPK3 (Cat #PA5-29636, Thermo Fisher Scientific, Inc.) and β-actin(Cat #MA5-15739, Thermo Fisher Scientific, Inc.), and then with the corresponding secondary antibody for 1h at room temperature. Immunofluorescence signals were detected using the ECL kit (Cell Signaling Technology, Inc.) and quantified using on the Gel Logic 2200 PRO Imaging System (Kodak, Rochester, NY, USA).
CD133 can serve as a specific surface marker for nasopharyngeal cancer stem cells[29]. Cells were harvested and counted, to a volume of 100 μL cell suspension, 5 μL CD133 antibody (Cat # 17-1338-42, Thermo Fisher Scientific, Inc.) mix was added, mixed and incubated for 20 minutes at 4°C in the dark and washed twice with 250 μL DPBS or FACS buffer. The stained cells were analyzed with fluorescence-activated cell sorting (FACS) by FCM (FACS Calibur, Becton Dickinson, Bedford, MA).
All statistical analyses were performed using SPSS software (v 21.0) for Windows (SPSS Inc., Chicago, IL, USA). The continuous data are represented as the mean ± standard deviation. One-way ANOVA was performed, and a p-value of < 0.05 was considered as statistically significant.
One thousand and forty-two circRNAs were significantly upregulated [fold change (FC) ≥ 2.0, p < 0.05] and 1558 circRNAs were significantly down-regulated [FC ≤ 0.5, p < 0.05] in IM group as compared to those in NC group [Figure 1A]. Among these, the expression of 307 circRNAs which were significantly up-regulated and 283 circRNAs which were significantly down-regulated were restored to non-significant levels after CUR intervention [Figure 1B 1-2]. Ninety-one circRNAs were significantly upregulated [FC ≥ 2.0, p < 0.05] and 11 circRNAs were significantly downregulated [FC ≤ 0.5, p < 0.05] in IC group as compared to those in IM group [Figure 1A]. Further, 1486 circRNAs were significantly upregulated [FC ≥ 2.0, p < 0.05] and 1687 circRNAs were significantly downregulated [FC ≤ 0.5, p < 0.05] in IC group as compared to those in NC group [Figure 1A]. The expression of circRNAS in the IM group was upregulated as compared to that in the NC group. The network diagram revealed that after CUR intervenetion, the IC group expressed the most significant reduction in the expression of 20 circRNAs and their corresponding 100 miRNAs as compared to the IM group [Figure 1C 1]. The same with the expression of circRNAs were decreased too [Figure 1C 2].
According to the restoration of expression of the top 20 circRNAs after CUR intervention (ranked by fold change), GO enrichment analysis of the corresponding 100 miRNAs was performed by FunRich (p < 0.05). The cellular component included GO terms nucleus, cytoplasm, Golgi apparatus, endosome, and lysosome [Figure 2A]. The molecular function included GO terms transcription factor activity, ubiquitin-specific protease activity, transcription regulator activity, receptor signaling complex scaffold activity, protein serine/threonine kinase activity, GTPase activity, and cytoskeletal protein binding [Figure 2B]. The biological process included GO terms regulation of nucleobase, nucleoside, nucleotide, and nucleic acid metabolism [Figure 2C]. The protein domain included GO terms HOX, BTB, ZNf-C4, RAS, CSP, HOLI, and S-TKc [Figure 2D]. The site of expression included GO terms of skin cancer, head and neck cancer, NPC, and embryonic stem cells (partly) [Figure 2E]. The catalog of somatic mutations in cancer (COSMIC) included GO terms cancer gene census gene list, large intestine, endometrium, and liver [Figure 2F].
The corresponding 100 miRNA analysis was performed using DIANA-mirpath. Proteoglycans in cancer, adherens junction, and signaling pathways regulating pluripotency of stem cells were chosen as the main pathways for further study. Six genes are simultaneously involved in the above three pathways, namely, CTNNB1, FGFR1, IGF1R, SMAD2, MAPK1, and MAPK3 [Figure 3A-1]. Subsequently, the 6 genes were used to find the corresponding miRNAs among the 100 miRNAs. Seven miRNAs were found to be simultaneously involved in the above three pathways, namely, hsa-miR-335-3p, hsa-miR-19a-3p, hsa-miR-544a, hsa-miR-4422, hsa-miR-9-5p, hsa-miR-450b-5p, and hsa-miR-4719 [Figure 3A-2]. The 7 miRNA were used to find the corresponding circRNA among the top 20 circRNAs, hsa_circRNA_102115, hsa_circRNA_104057, hsa_circRNA_103572, hsa_circRNA_004868, hsa_circRNA_100912, hsa_circRNA_102857, and hsa_circRNA_402801. Finally, the 7 circRNA-related miRNAs and mRNA interaction network was constructed [Figure 3B].
We used qRT-PCR to verify the changing trends in the expression of the selected circRNAs and the corresponding miRNAs and mRNAs. The expression of hsa_circRNA_102115, hsa_circRNA_104057, hsa_circRNA_103572, and hsa_circRNA_402801 were found to be changed dramatically in both IM and IC groups [p < 0.05] [Figure 4 A1]. The expression of hsa-miR-335-3p, hsa-miR-544a, hsa-miR-4422, hsa-miR-9-5p, hsa-miR-450b-5p were found to differ significantly in the IM group as compared to those in NC group. Expression of hsa-miR-335-3p, hsa-miR-450b-5p, and hsa-miR-4422, however, were restored significantly [p < 0.05] [Figure 4 A2]. On the other hand, the expression of IGF1R and MAPK1 was found to be changed dramatically in IM group as compared to those in NC group, and expression of MAPK1 was restored significantly [p < 0.05] [Figure 4 A3]. Also, the same results of WB can verify this interaction network in a protein level, the expression of IGF1R and MAPK1 in protein level is significantly lower in IM cells [p < 0.05]. And compared to those in NC group, and expression of MAPK1 was restored significantly [p < 0.05] [Figure 4 B].
Changes in the expression of circRNAs and the corresponding miRNAs as analyzed by microarray. (A) Hierarchical clustering heatmap showing the expression of all the target circRNAs and the most upregulated and downregulated circRNAs in the three groups. (B1) 307 upregulated-restored circRNAs after exposure to curcumin. (B2) 283 downregulated-restored circRNAs after exposure to curcumin. (C1) The top 20 upregulated-restored circRNAs and the corresponding miRNAs. (C2) The top 20 downregulated-restored circRNAs and the corresponding miRNAs.
Corresponding miRNA enrichment by GO analysis. (A) Cellular component. (B) Molecular function. (C) Biological process. (D) Protein domain. (E) Site of expression. (F) Catalogue of Somatic Mutations in Cancer (COSMIC).
In the beginning, we have ensured the radiosensitization of three groups cells are make sense. Clonogenic survival assay can reveal the survival score of irradiated cells veritably and is thus widely used in measuring the radio-sensitivity of cells. The higher survival fraction under 2 Gy radiation (SF2) of NC cells was 0.53, IM cells were 0.78, IC cells was 0.62 obtained from the linear-quadratic formulation (L-Q) of cell-absorbed dose survival equation [Figure 5 A1, A3]. In a multi-target single-hit model, the sensitization enhancement ratio (SER) of IM/IC was 0.46; IC/NC was 0.76 [Figure 5 A2, A4].
To further validate our hypothesis, the amount of CD133+ cells in NC was 2.39±0.244%, significantly increased to 15.73±1.93% in IM [p<0.05]. After treated with CUR, decreased to 5.51±0.70% in IC [p<0.05]. [Figure 5 B1-B4]. The wound healing assay also showed that the transferability in the IM group was enhanced, and the transferability in IC group was weakened after the intervention [p < 0.05] [Figure 5 C1-C2].
In this study, we found that several circRNAs and their corresponding miRNAs were related to the radiation sensitivity of NPC, and curcumin was found to restore the expression of some of these circRNAs. The circRNAs serve as natural miRNA sponges by competitively binding to miRNA response elements (MREs) and suppress their expression and function. The miRNAs in cancer are commonly involved in destabilization and degradation of mRNAs [30]. This regulatory pathway may be linked to the changes in tumor stem-like properties of radiation-resistant NPC cells. Tumor stem-like cells have been shown to exist in a variety of tumors including NPC [7]. The results of flow cytometry in this study have confirmed the tumor stem-like cells in CNE-2 cell line incredible increase after long term exposure to radiation, and CUR can reverse this to some extent. And that just confirmed our hypothesis, continuous exposure to radiation-induced abnormal expression of circRNAs leading to the differentiation of nasopharyngeal epithelial stem cells along with an attempt of self-renewal to replace the impaired cells. The results of GO analysis of circRNAs have shown that circRNAs have a high rate of expression in skin cancer, head and neck cancer, NPC, and embryonic stem cells.
DNA double chain damage repair is an essential mechanism of resistance of tumor cells to radiotherapy [31]. DNA damage can induce DNA damage response signaling (DDR signaling) in the tumor cells. This reaction enables the cells to eliminate or reduce damage and allows to stimulate apoptotic pathways to prevent severe mutations. Studies have shown that resistance to radiotherapy is associated with DDR signaling in the tumor stem cells [32]. The tumor stem-like cells have high malignant potentials and strong proliferative and transformation properties [33]. Under 2 Gy radiation, the higher survival fraction (SF2) indicates stronger radio- resistivity, CUR can reduce SF2 increasing induced by radiation in IM CNE-2 cells. Also, the changes of SER in three groups showed CUR could radiosensitize CNE-2 cells in this study. In the meantime, our research found that NPC CNE-2 cells had a significantly increased rate of metastasis after acquiring resistance to radiation, while the transfer capacity of the cells was restored to a weaker magnitude after treatment with curcumin. As we all know, the direct impact and potential of NPC radioresistant had been extensively investigated and elucidated in a great number of previous studies with very consistent findings and conclusions. However, it seems almost nobody cares about the different mechanisms induced NPC radioresistant between long term and transient exposure to radiation. And does the amount of CD133+ cells changed in these two radioresistance NPC cells? How can we decrease the CD133+ cells in radiosensitive CNE-2 cells? We have taken a year to create a stable radioresistant NPC cell line and trying to figure out these concerns.[34] The assessment of the up- and down-stream targets would be studied by CRIPSR-Cas9 and NAVI system[35].These mechanisms could be used for gene therapy NPC radioresistance in vivo, animal models even clinical.
Pathway analyzed with DIANA-mirpath and circRNA-miRNA-mRNA interaction networks. (A1) 6 genes were involved in the three pathways simultaneously. Proteoglycans, adherens junction, and signaling pathways regulating pluripotency of stem cells were analyzed with DIANA-mirpath. (A2) 7 miRNAs were simultaneously involved in the three pathways from the 100 miRNAs including the top 20 miRNAs (ranked by fold change) which restored the expression of circRNAs. (B) The circRNA-miRNA-mRNA interaction network involving the three pathways, 6 genes, 7 circRNAs, and 7 corresponding miRNAs.
Verification of the circRNA-miRNA-mRNA interaction network. (A1) qRT-PCR detection of circRNA expression in the three groups. (A2) Levels of target miRNAs for circRNA in the three groups. (A3) Levels of target mRNAs for miRNAs in the three groups. The expression of each RNA was calculated using 2-△△Ct equation. Compared to NC group: *p < 0.05, and compared to IM group: #p < 0.05. (B) WB analysis of selected protein expression. Compared to NC group: *p < 0.05, and compared to IM group: #p < 0.05.
CircRNAs are a particular type of noncoding RNA molecules that lack 5′-3′ ends and poly-A tail. CircRNAs have closed ring structures that are not affected by RNA excision enzyme [36]. CircRNAs have high abundance, stability, biological conservatism, and tissue specificity. The mRNA precursor is cut and the shear supply is connected to the upstream shear receptor through a splicing mechanism called back-splices. CircRNAs may enhance or inhibit carcinogenesis by inhibiting miRNAs associated with differentiation, proliferation, migration, and carcinogenic effects.
Validation of circRNAs and their corresponding miRNAs and mRNAs by bioinformatical analysis through screening demonstrated that the resistance of NPC CNE-2 cells to radiation was regulated by the change in the “hsa_circRNA_102115”-“hsa-miR-335-3p” -“IGF1R/MAPK1” network. Curcumin restored the sensitivity of NPC CNE-2 cells to radiation by regulating the “hsa_circRNA_102115”-“hsa-miR-335-3p”-“MAPK1” network. The results of the GO analysis also showed that the primary molecular functions which were involved were transcription factor activity and transcription regulator activity, while the main biological processes which were involved were regulation of nucleobase, nucleoside, nucleotide, and nucleic acid metabolism. Studies have shown that circRNAs play a vital role in the regulation of post-transcriptional gene expression [37]. RNA binding proteins are involved in a variety of biological activities in the post-transcription levels, including cell proliferation, differentiation, movement, apoptosis, aging, and cell response to oxidative stress. RNA binds to these proteins to form an RNA-protein complex (RPCs), which can be used as an RNA binding protein sponge. These RPCs regulate RNA binding proteins and miRNAs and then interact with the corresponding linear RNAs [37, 38].
Detection of cell biology changes. The dose-survival curve of NC and IM obtained from L-Q matching. (A1) The dose-survival curve of NC and IM obtained from multi-target single-hit model matching. (A2) The dose-survival curve of NC and IC obtained from L-Q matching. (A3) The dose-survival curve of NC and IC obtained from multi-target single-hit model matching. (A4) The amount of CD133+ cells in three groups. (B1-4) Compared to NC group: *p < 0.05, and compared to IM group: #p < 0.05. Wound healing assay among the three groups. (C2) Gap closure (%) in each group. Compared to NC group: *p < 0.05, and compared to IM group: #p < 0.05. (C1)
In this study, we found that the resistance of NPC CNE-2 cells to radiation was related to the tumor stem-like cells present in it. This might be related to the changes in the interaction network "hsa_circRNA_102115"-"hsa-miR-335-3p"-"IGF1R/MAPK1" induced by radiation. Curcumin could restore the radiation sensitivity of the NPC cells by regulating the change in expression of the "hsa_circRNA_102115"-"hsa-miR-335-3p"-"MAPK1" interaction network.
NC: negative control; IM: irradiation model; IC: irradiation and curcumin.
Supplementary table.
The authors have no financial conflicts of interest. This work was supported by the National Natural Science Foundation of China (grant no. 81673718) and Natural Science Foundation of Guangdong province (grant No. 2016A030313833) and Technology Project of Guangdong province (grant no. 2016A020226034) and Baiyun District of Guangzhou science and technology project (2016-KJ-001).
The authors have declared that no competing interest exists.
1. Cao SM, Simons MJ, Qian CN. The prevalence and prevention of nasopharyngeal carcinoma in China. Chinese journal of cancer. 2011;30:114-9
2. Nor Hashim NA, Ramzi NH, Velapasamy S, Alex L, Chahil JK, Lye SH. et al. Identification of genetic and non-genetic risk factors for nasopharyngeal carcinoma in a Southeast Asian population. Asian Pacific journal of cancer prevention: APJCP. 2012;13:6005-10
3. Zeng Q, Hong MH, Shen LJ, Meng XQ, Guo X, Qian CN. et al. Nomograms for predicting long-term survival in patients with non-metastatic nasopharyngeal carcinoma in an endemic area. Oncotarget. 2016;7:29708-19
4. Yu YH, Xia WX, Shi JL, Ma WJ, Li Y, Ye YF. et al. A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients. Chinese journal of cancer. 2016;35:59
5. Du C, Ying H, Zhou J, Hu C, Zhang Y. Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma. International Journal of Clinical Oncology. 2013;18:464-71
6. Wang J, Guo LP, Chen LZ, Zeng YX, Lu SH. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer research. 2007;67:3716-24
7. Chan KC, Chan LS, Ip JC, Lo C, Yip TT, Ngan RK. et al. Therapeutic targeting of CBP/beta-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin. Sci Rep. 2015;5:9979
8. Aggarwal BB, Deb L, Prasad S. Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses. Molecules. 2014;20:185-205
9. Fan H, Shao M, Huang S, Liu Y, Liu J, Wang Z. et al. MiR-593 mediates curcumin-induced radiosensitization of nasopharyngeal carcinoma cells via MDR1. Oncol Lett. 2016;11:3729-34
10. Gersey ZC, Rodriguez GA, Barbarite E, Sanchez A, Walters WM, Ohaeto KC. et al. Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species. BMC cancer. 2017;17:99
11. Buhrmann C, Kraehe P, Lueders C, Shayan P, Goel A, Shakibaei M. Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT. PloS one. 2014;9:e107514
12. Baharuddin P, Satar N, Fakiruddin KS, Zakaria N, Lim MN, Yusoff NM. et al. Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines. Oncol Rep. 2016;35:13-25
13. Mukherjee S, Mazumdar M, Chakraborty S, Manna A, Saha S, Khan P. et al. Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/beta-catenin negative feedback loop. Stem cell research & therapy. 2014;5:116
14. Greene J, Baird AM, Brady L, Lim M, Gray SG, McDermott R. et al. Circular RNAs: Biogenesis, Function and Role in Human Diseases. Frontiers in molecular biosciences. 2017;4:38
15. Jens M. Circular RNAs Are a Large Class of Animal RNAs with Regulatory Potency. Dissecting Regulatory Interactions of RNA and Protein: Combining Computation and High-throughput Experiments in Systems Biology. Cham: Springer International Publishing. 2014 p. 69-80
16. Chen L, Zhang S, Wu J, Cui J, Zhong L, Zeng L. et al. circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family. Oncogene. 2017;36:4551-61
17. Wang H, Xiao Y, Wu L, Ma D. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-000911/miR-449a pathway in breast carcinogenesis. Int J Oncol. 2018;52:743-54
18. Ma HB, Yao YN, Yu JJ, Chen XX, Li HF. Extensive profiling of circular RNAs and the potential regulatory role of circRNA-000284 in cell proliferation and invasion of cervical cancer via sponging miR-506. American journal of translational research. 2018;10:592-604
19. Yan N, Xu H, Zhang J, Xu L, Zhang Y, Zhang L. et al. Circular RNA profile indicates circular RNA VRK1 is negatively related with breast cancer stem cells. Oncotarget. 2017;8:95704-18
20. Ke Z, Xie F, Zheng C, Chen D. CircHIPK3 promotes proliferation and invasion in nasopharyngeal carcinoma by abrogating miR-4288-induced ELF3 inhibition. J Cell Physiol. 2019;234:1699-706
21. Kong L, Zhang YW, Hu CS, Guo Y. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma. Chinese journal of cancer. 2010;29:551-5
22. Kristensen LS, Okholm TLH, Veno MT, Kjems J. Circular RNAs are abundantly expressed and upregulated during human epidermal stem cell differentiation. RNA biology. 2018;15:280-91
23. O'Leary VB, Smida J, Matjanovski M, Brockhaus C, Winkler K, Moertl S. et al. The circRNA interactome-innovative hallmarks of the intra- and extracellular radiation response. Oncotarget. 2017;8:78397-409
24. Wang Q, Fan H, Liu Y, Yin Z, Cai H, Liu J. et al. Curcumin enhances the radiosensitivity in nasopharyngeal carcinoma cells involving the reversal of differentially expressed long non-coding RNAs. Int J Oncol. 2014;44:858-64
25. Liao M, Li Y, Kianifard F, Obi E, Arcona S. Cluster analysis and its application to healthcare claims data: a study of end-stage renal disease patients who initiated hemodialysis. BMC nephrology. 2016;17:25
26. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research. 2003;13:2498-504
27. Vlachos IS, Zagganas K, Paraskevopoulou MD, Georgakilas G, Karagkouni D, Vergoulis T. et al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res. 2015;43:W460-6
28. Pathan M, Keerthikumar S, Chisanga D, Alessandro R, Ang CS, Askenase P. et al. A novel community driven software for functional enrichment analysis of extracellular vesicles data. J Extracell Vesicles. 2017;6:1321455
29. Zhuang HW, Mo TT, Hou WJ, Xiong GX, Zhu XL, Fu QL. et al. Biological characteristics of CD133(+) cells in nasopharyngeal carcinoma. Oncol Rep. 2013;30:57-63
30. Andres-Leon E, Cases I, Alonso S, Rojas AM. Novel miRNA-mRNA interactions conserved in essential cancer pathways. Sci Rep. 2017;7:46101
31. Rusin P, Walczak A, Zwierzchlejska A, Olszewski J, Morawiec-Bajda A, Kaczmarczyk D. et al. DNA damage and repair of head and neck cancer cells after radio- and chemotherapy. Z Naturforsch C. 2009;64:601-10
32. Lee SY, Jeong EK, Ju MK, Jeon HM, Kim MY, Kim CH. et al. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Mol Cancer. 2017;16:10
33. Wang L, Fan J, Hitron JA, Son YO, Wise JT, Roy RV. et al. Cancer Stem-Like Cells Accumulated in Nickel-Induced Malignant Transformation. Toxicol Sci. 2016;151:376-87
34. Zhu D, Huang M, Fang M, Li A, Liu Z, Shao M. et al. Induction of radioresistant nasopharyngeal carcinoma cell line CNE-2R by repeated high-dose X-ray irradiation. J International Journal of Radiation Research. 2019;17:47-55
35. Brown A, Woods WS, Perez-Pinera P. Multiplexed Targeted Genome Engineering Using a Universal Nuclease-Assisted Vector Integration System. ACS Synth Biol. 2016;5:582-8
36. Zhang Y, Liang W, Zhang P, Chen J, Qian H, Zhang X. et al. Circular RNAs: emerging cancer biomarkers and targets. J Exp Clin Cancer Res. 2017;36:152
37. Conn SJ, Pillman KA, Toubia J, Conn VM, Salmanidis M, Phillips CA. et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160:1125-34
38. Ashwal-Fluss R, Meyer M, Pamudurti NR, Ivanov A, Bartok O, Hanan M. et al. circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56:55-66
Corresponding authors: Qin Fan, School of Traditional Chinese Medicine, Southern Medical University, 1063 Shatai Road, Guangzhou, 510515, China. Tel: +86 13688859758; Email addresses: fqincom or Zhixian Mo, School of Traditional Chinese Medicine, Southern Medical University, 1063 Shatai Road, Guangzhou, 510515, China. Tel.: +86 20 61648261, Fax: +86 2061648244. Email address: cherrymocom
Received 2019-8-20
Accepted 2020-1-4
Published 2020-2-10